{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:53Z","timestamp":1787010173868,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Breast cancer (BC) is the most diagnosed cancer worldwide. Multiple myeloma (MM) is a hematologic malignancy characterized by the overproduction of monoclonal antibodies in the bone marrow. Systemic lupus erythematosus (SLE) is distinguished by the aberrant activity of the immune system with heterogeneous clinical manifestations. The coexistence of more than one major illness in a patient can present a diagnostic challenge for clinical physicians, especially when the comorbid diseases share a similar clinical presentation. Herein, we report an unusual case of secondary synchronous diagnosis of MM and SLE after BC treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 69-year-old female patient with breast cancer experienced severe skin itching and rashes on the face, anterior chest wall, back, and trunk for two days before admission. She had high levels of immunoglobulin and anti-nuclear antibodies; low levels of complements 3 and 4; positive anti-cardiolipin-IgM, anti-beta 2 glycoprotein-1 (anti-\u03b22GP1) antibodies, and lupus anticoagulant results at serological testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>The postoperative pathology report showed ductal carcinoma in situ in the right breast. SLE was confirmed based on the 2019 European League Against Rheumatism\/American College of Rheumatology (EULAR\/ACR) criteria. IgG-\u03ba type multiple myeloma was confirmed by bone marrow biopsy, and the patient was synchronously diagnosed with SLE and MM after BC treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Glucocorticoids and immunosuppressive agents, including intravenous hydrocortisone (5\u2009g every 8 hours) and oral hydroxychloroquine (Plaquenil) (200\u2009mg twice daily) were administered to treat SLE. One capsule of thalidomide 50\u2009mg was administered orally every night at bedtime for MM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient died two days later, shortly after the administration of drugs, due to multiple organ failures secondary to pneumonia and respiratory failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This is a case of MM and SLE after BC treatment. The present challenge was the early detection and accurate diagnosis of the secondary major illnesses, as the clinical manifestations were similar and non-specific between these two diseases. Awareness and prompt recognition of the common clinical symptoms of SLE and MM should be considered by clinical physicians to avoid delayed diagnoses and facilitate early treatment for a better prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000030320","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T12:16:18Z","timestamp":1662120978000},"page":"e30320","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A case report of secondary synchronous diagnosis of multiple myeloma and systemic lupus erythematosus after breast cancer treatment: A CARE-compliant article"],"prefix":"10.1097","volume":"101","author":[{"given":"Pei-Hsin","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Nursing, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, Taiwan"},{"name":"School of Nursing, National Yang Ming Cho Tung University, Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Hsin","family":"Tung","sequence":"additional","affiliation":[{"name":"School of Nursing, National Yang Ming Cho Tung University, Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Husan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of pathology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Po","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of hematology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Lun","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of chest medicine, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9670-5571","authenticated-orcid":false,"given":"Chin-Yao","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Breast Medical Center, Taichung Tzi-Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.soncn.2017.05.012","article-title":"Pathobiology and diagnosis of multiple myeloma","volume":"33","author":"Brigle","year":"2017","journal-title":"Semin Oncol Nurs"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3816\/CLML.2010.n.080","article-title":"Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma","volume":"10","author":"Talamo","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1200\/EDBK_159009","article-title":"Updated diagnostic criteria and staging system for multiple myeloma","volume":"35","author":"Rajkumar","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R6-20250504","first-page":"79","article-title":"To investigate the age at onset and gender distribution of patients with systemic lupus erythematosus in Taiwan","volume":"18","author":"Chen","year":"2020","journal-title":"J Health Manag"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J Autoimmun"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.2009.09472.x","article-title":"Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients","volume":"162","author":"Vera-Recabarren","year":"2010","journal-title":"Br J Dermatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"100042","DOI":"10.1016\/j.jtauto.2020.100042","article-title":"Urinary biomarkers in lupus nephritis","volume":"3","author":"Arag\u00f3n","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0039-1685537","article-title":"Pulmonary complications of systemic lupus erythematosus","volume":"40","author":"Hannah","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"R11-20250504","first-page":"58","article-title":"Haematology: multiple myeloma","volume":"19","author":"Firth","year":"2019","journal-title":"Clin Med (Lond)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(12)70041-4","article-title":"Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England","volume":"13","author":"Lyratzopoulos","year":"2012","journal-title":"Lancet Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2340\/0001555558527530","article-title":"Systemic lupus erythematosus with multiple myeloma","volume":"58","author":"Pehamberger","year":"1978","journal-title":"Acta Derm Venereol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/1042819021000037949","article-title":"Multiple myeloma associated with systemic lupus erythematosus","volume":"44","author":"Vaiopoulos","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"R16-20250504","first-page":"96","article-title":"SLE and multiple myeloma, a rare and unusual association","volume":"22","author":"Humayun","year":"2014","journal-title":"J Med Sci"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/cancers11101463","article-title":"Risk of hematologic malignant neoplasms after postoperative treatment of breast cancer","volume":"11","author":"Jabagi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e187147","DOI":"10.1001\/jamanetworkopen.2018.7147","article-title":"Evaluation of the incidence of hematologic malignant neoplasms among breast cancer survivors in France","volume":"2","author":"Jabagi","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R19-20250504","first-page":"620","article-title":"Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study","volume":"56","author":"Hsu","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R20-20250504","first-page":"194","article-title":"Multiple myeloma emerging after chemotherapy for breast cancer: case presentation and a brief review","volume":"23","author":"G\u00fcrel","year":"2015","journal-title":"Van Tip Derg Med J"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12032-008-9056-0","article-title":"Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer","volume":"25","author":"Marinopoulos","year":"2008","journal-title":"Med Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:35:09Z","timestamp":1746318909000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":20,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030320","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}